3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Breast Neoplasms
10
Colorectal Neoplasms
8
Lung Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Pancreatic Neoplasms
5
Neoplastic Cells, Circulating
4
Neoplasm Metastasis
4
Biliary Tract Neoplasms
4
Recurrence
3
Prostatic Neoplasms
3
Oropharyngeal Neoplasms
3
Neoplasm, Residual
3
Disease
3
Squamous Cell Carcinoma of Head and Neck
2
Nevi and Melanomas
2
Neuroendocrine Tumors
2
Nasopharyngeal Carcinoma
2
NSCLC
2
Melanoma
2
Head and Neck Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Hepatocellular
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Smoking
1
Sarcoma, Ewing
1
Interventions
Doxorubicin
6
Radiotherapy
5
selinexor
4
pazopanib
3
Sirolimus
3
Ifosfamide
3
AZD 6244
3
pembrolizumab
2
fludarabine phosphate
2
Radiation Dose Hypofractionation
2
Nivolumab
2
Etoposide
2
thymoglobulin
1
temsirolimus
1
tazemetostat
1
sotigalimab
1
ribociclib
1
pexidartinib
1
pegfilgrastim
1
liposomal doxorubicin
1
lentiviral minigene vaccine of COVID-19 coronavirus
1
ixazomib
1
fludarabine
1
decitabine and cedazuridine drug combination
1
X-Rays
1
Thiotepa
1
Tacrolimus
1
Surgical Procedures, Operative
1
Sunitinib
1
Stem Cell Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neurofibrosarcoma
×
Liquid Biopsy
×
Clear all
NCT06515860
2026-01-09
NF1-TED
Boston Children's Hospital
Recruiting
1,000 enrolled